Article Information
History
- November 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Martina Recalde, PhD student1,2,
- Andrea Pistillo, statistician1,
- Sergio Fernandez-Bertolin, data scientist1,
- Elena Roel, PhD student1,2,
- Maria Aragon, SIDIAP coordinator1,
- Heinz Freisling, scientist3,
- Daniel Prieto-Alhambra, Professor of pharmaco- and device epidemiology4,†,
- Edward Burn, post-doctoral researcher1,4,* and
- Talita Duarte-Salles, senior epidemiologist1,*,†
- 1Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
- 2Universitat Autònoma de Barcelona, Spain
- 3International Agency for Research on Cancer (IARC-WHO), 150 Cours Albert Thomas, 69008 Lyon, France
- 4Centre for Statistics in Medicine, NDORMS, University of Oxford
- ↵†CORRESPONDING AUTHORS
Daniel Prieto-Alhambra, Botnar Research Centre, Windmill Road, OX37LD, Oxford, United Kingdom, daniel.prietoalhambra{at}ndorms.ox.ac.uk, Talita Duarte-Salles, Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via Corts Catalanes, 587 àtic, 08007 Barcelona - Spain tduarte{at}idiapjgol.org
Posted November 28, 2020.
Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a population-based multi-state cohort analysis including 2,524,926 people in Catalonia, Spain
